Decreased trkA gene expression within basal forebrain neurons in Alzheimer's disease

Neuroreport. 1996 Dec 20;8(1):25-9. doi: 10.1097/00001756-199612200-00006.

Abstract

In situ hybridization for TrkA mRNA was combined with quantitative optical densitometry to evaluate whether the expression of this gene is altered within cholinergic basal forebrain neurons (CBF) in Alzheimer's disease (AD). TrkA mRNA within individual nucleus basalis neurons was significantly reduced (66%) in AD cases relative to aged controls. Reverse transcription polymerase chain reaction quantitative analyses confirmed that TrkA mRNA levels decreased markedly in AD. In contrast, expression of the gene coding for for the low affinity p75NTR was not significantly altered in AD relative to aged controls. These data indicate that there is a selective defect in trkA gene expression in AD, supporting the hypothesis that the degeneration of CBF neurons seen in this disease results from impaired nerve growth factor trophic support.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / metabolism*
  • Alzheimer Disease / pathology
  • Basal Ganglia / metabolism*
  • Basal Ganglia / pathology
  • Carrier Proteins / biosynthesis
  • Carrier Proteins / genetics*
  • Densitometry
  • Humans
  • In Situ Hybridization
  • Membrane Proteins / biosynthesis
  • Membrane Proteins / genetics*
  • Middle Aged
  • Neurons / metabolism*
  • Parasympathetic Nervous System / metabolism
  • Polymerase Chain Reaction
  • Prosencephalon / metabolism*
  • Prosencephalon / pathology
  • RNA, Messenger / biosynthesis
  • Receptor, trkA*

Substances

  • Carrier Proteins
  • Membrane Proteins
  • RNA, Messenger
  • Receptor, trkA